SEC Form D · Amendment · filed October 6, 2021
Cyrus Biotechnology, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Chad Waite · Seattle, WADirectorMark Benjamin · Seattle, WAExecGus Tai · Seattle, WADirectorLucas Nivon · Seattle, WAExec · DirectorYifan Song · Seattle, WAExec · DirectorJoshua F. Sobeck · New York, NYDirectorDavid Chao · Houston, TXDirectorGijs F. Van Thiel · New York, NYExec · DirectorNicholas J. Esterline · WICHITA, KSExecRobert C. Green · Cambridge, MAExec · DirectorPaul Martino · SAN FRANCISCO, CAExec · DirectorNicholas Manolelis · Los Angeles, CADirectorJeff Bicksler · Atlanta, GAExec · DirectorJames Kim · Alameda, CAExecBrandon Alexandroff · Longboat Key, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗